-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Nektar Therapeutics quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Nektar Therapeutics Costs and Expenses for the quarter ending June 30, 2024 was $73.3M, a 3.05% increase year-over-year.
- Nektar Therapeutics Costs and Expenses for the twelve months ending June 30, 2024 was $257M, a 32.4% decline year-over-year.
- Nektar Therapeutics annual Costs and Expenses for 2023 was $354M, a 24.4% decline from 2022.
- Nektar Therapeutics annual Costs and Expenses for 2022 was $468M, a 14.6% decline from 2021.
- Nektar Therapeutics annual Costs and Expenses for 2021 was $548M, a 5.19% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)